Reduce-bp
Many factors contribute to gaps in suboptimal blood pressure control and disease outcomes, including physician inertia, low patient adherence to prescribed antihypertensive medications and lifestyle. Reducing Ethnic and racial Disparities by improving Undertreatment, Control, and Engagement in Blood Pressure management with health information technology (REDUCE-BP) is an ongoing pragmatic randomized controlled trial being conducted in partnership with Advocate Aurora Health. It uses a multicomponent intervention within the electronic health record to improve guideline concordance and address health-related social needs with the ultimate goal of improving disease control for individuals with uncontrolled hypertension. The trial is being conducted at 24 clinics in the Chicago area and involves more than 350 primary care providers and more than 10,000 patients. Results will be presented in the fall of 2024.
ClinicalTrials.gov: NCT05030467
​
Co-Principal Investigators: Niteesh Choudhry, MD, PhD and Julie Lauffenburger, PharmD, PhD
Reducing ethnic and racial disparities by improving undertreatment, control, and engagement in blood pressure management with health information technology (REDUCE-BP) hybrid effectiveness-implementation pragmatic trial: Rationale and design
Lauffenburger JC, Khatib R, Siddiqi A, Albert MA, Keller PA, Samal L, Glowacki N, Everett ME, Hanken K, Lee SG, Bhatkhande G, Haff N, Sears ES, Choudhry NK
Am Heart J
2023 January